Alcare participated in the Combined GIHep & Singapore Hepatology Conference 2024 held in Grand Hyatt Hotel, Singapore, from 25 – 28 July 2024. The event brought together leading clinicians and health professionals in the field of Gastroenterology and Hepatology.
During the event, Alcare presented the latest biodegradable biliary and pancreatic stents, developed by Q3 Medical Group, designed to improve quality of life outcomes for patients by reducing the need for secondary procedures.
Attendees from across the medical community expressed keen interest in the potential of the biodegradable technologies revolutionise the healthcare journey in reducing unnecessary hospital stays and easing the burden on both patients and healthcare institutions.
